Laboratorio Reig Jofre, S.A. (FRA:FEQ1)
2.700
+0.040 (1.50%)
At close: Dec 4, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Pharmaceutical Services | 256.19M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Services Growth | 18.06% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nutritional Supplements | 59.90M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nutritional Supplements Growth | 10.62% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Spain | 141.06M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Spain Growth | 18.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| European Union | 115.47M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| European Union Growth | 4.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia | 25.52M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Growth | 62.90% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Europe | 22.28M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Europe Growth | 33.15% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Africa | 5.18M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Africa Growth | 18.44% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Americas | 4.26M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Americas Growth | 26.07% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Oceania | 2.32M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Oceania Growth | 15.34% |
Log In |
Log In |
Log In |
Log In | Upgrade
|